Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)

View source ↗

Summary

Clinical trial update for the LinkSymphoKnee Ultra-congruent Total Knee Replacement System shows enrollment by invitation for osteoarthritis of the knee and kne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LinkSymphoKnee (LSK) Total Knee Replacement System

Snippet

Sponsor: LinkBio Corp. | Conditions: Osteoarthritis (OA) of the Knee, Fracture | Status: ENROLLING_BY_INVITATION